ClinicalTrials.govpublic full text
Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients
acute myeloid leukemia, aml, rapamycin, elderly, elderly patients not eligible for intensive chemotherapy, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 881557
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.